Healthcare

This edition of the Genetic TOE depicts the current landscape and the new life sciences trends across cancer therapy. In particular, next generation cancer therapies, novel targets and genetic technologies, and personalized vaccines have been profiled. The corresponding patent scenario is depicted along with the industry interactions. The Genetic...

This edition of Inside R&D TOE depicts innovations in energy with biofuels, agriculture empowered by nanotech, medicine addressing Alzheimer's disease, financials through blockchain, and technology developments for drones. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually al...

This edition of the Genetic TOE depicts the current landscape and the new life sciences trends across technologies empowering diagnostics. The technology synergy observed to address current concerns in cancer diagnostics and the development of monoclonal antibodies to target Parkinson's disease are illustrated. The corresponding patent scenario is ...

This edition of Inside R&D TOE depicts innovations in medicine, sustainability, and electronics. In particular, breast cancer, light-emitting diodes, water treatment technologies, and perfume extraction are depicted. Inside R&D TechVision Opportunity Engine (TOE) covers global innovations that are in research and development in virtually all tech...

The latest edition of the Medical Diagnostics and Imaging TOE profiles exciting innovations from South Korea. Korea is home to some of the largest imaging and instrumentation companies, besides being a hotbed for biomedical innovation in academia. Each of these innovations have been conducted or led by Korean scientists and companies, and are in va...

This edition of the Genetic TOE focuses on immunotherapies. Collaborations between Bristol-Myers Squibb (BMS) and Five Prime Therapeutics for developing Immunotherapies, Celgene and Jounce Therapeutics for developing a monoclonal antibody for cancer, Merck KGaA and Pfizer for developing ligand 1 checkpoint inhibitors, and Merck & Co. and Ablynx for...

TechVision's latest research service from the medical imaging technology cluster highlights the emerging trends and innovations in ultrasound imaging. Although the use of ultrasound for medical applications have been in use for a few decades now, the last few years have witnessed a rapid expansion of their applications, and a surge in the intensity...

Development of nanotechnology-based medical devices enables major cost reduction across the medical device value chain, as it offers very high bargaining power to suppliers of medical device OEMs (original equipment manufacturers). This research service (RS) analyzes the need for adoption of nanotechnologies in the medical devices industry, which a...

Fluctuations in consumer purchasing behavior across the world, emerging fashion trends shaping consumer perceived value, and high preference for personalized products are factors that are responsible for opportunities for 3D printing within the personal care industry. This research service (RS) evaluates the role played by 3D printing technologies ...